| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 15.168 | 30.388 | 27.161 | 15.890 | 32.760 | 51.520 | 58.988 |
| Total Income - EUR | - | - | - | 15.168 | 30.388 | 27.161 | 15.890 | 32.760 | 51.570 | 58.988 |
| Total Expenses - EUR | - | - | - | 168 | 5.074 | 9.075 | 8.903 | 8.687 | 13.520 | 30.280 |
| Gross Profit/Loss - EUR | - | - | - | 15.000 | 25.314 | 18.086 | 6.987 | 24.073 | 38.050 | 28.708 |
| Net Profit/Loss - EUR | - | - | - | 14.545 | 24.402 | 17.271 | 6.510 | 23.077 | 37.534 | 23.226 |
| Employees | - | - | - | 0 | 1 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Damafi Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.116 | 4.237 | 3.043 | 1.887 | 823 | 0 | 0 |
| Current Assets | - | - | - | 13.629 | 21.808 | 16.294 | 8.561 | 24.341 | 40.459 | 28.918 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 1.371 | 1.380 | 558 | 0 | 2.208 | 8.554 | 5.856 |
| Cash | - | - | - | 12.258 | 20.428 | 15.736 | 8.561 | 22.132 | 31.905 | 23.063 |
| Shareholders Funds | - | - | - | 43 | 1.273 | 1.249 | 1.221 | 1.225 | 2.072 | 2.061 |
| Social Capital | - | - | - | 43 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | - | - | - | 14.702 | 24.772 | 18.089 | 9.227 | 23.939 | 38.386 | 26.858 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Damafi Med Srl